| dc.contributor.author |
Aladağ, M. |
|
| dc.date.accessioned |
2019-07-25T06:54:23Z |
|
| dc.date.available |
2019-07-25T06:54:23Z |
|
| dc.date.issued |
2018 |
|
| dc.identifier.citation |
Aladağ, M. (2018). Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program. Cilt:68, 301-301 ss. |
tr_TR |
| dc.identifier.uri |
http://hdl.handle.net/11616/12931 |
|
| dc.language.iso |
eng |
tr_TR |
| dc.publisher |
Elsevıer scıence bv, po box 211, 1000 ae amsterdam, netherlands |
tr_TR |
| dc.rights |
info:eu-repo/semantics/restrictedAccess |
tr_TR |
| dc.title |
Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program |
tr_TR |
| dc.type |
article |
tr_TR |
| dc.relation.journal |
Journal of hepatology |
tr_TR |
| dc.contributor.department |
İnönü Üniversitesi |
tr_TR |
| dc.identifier.volume |
68 |
tr_TR |
| dc.identifier.startpage |
301 |
tr_TR |
| dc.identifier.endpage |
301 |
tr_TR |